CVS Caremark Corp. to pay almost $37 million on retail dispensing practices for ranitidine

CVS Caremark has reached a settlement agrement with Department of Jutice to resolve an investigation
into the practice of dispensing the generic ranitidine in capsule rather than tablet form

Drug News and Information

New Products